AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20452196 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC250 (salmeterol/fluticasone propionate combination 50/250 microg bd)
Number of subjects: 178
Study 20452196 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC500 (salmeterol/fluticasone propionate combination 50/500 microg bd)
Number of subjects: 178
Study 20452196 — intervention group
Group type: COMPARATOR
Intervention: SFC250
Number of subjects: 178
Study 20452196 — intervention group
Group type: COMPARATOR
Intervention: SFC500
Number of subjects: 178
Study 17592691 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported discharge (home treatment)
Number of subjects: 44
Study 17592691 — intervention group
Group type: COMPARATOR
Intervention: Conventional in-patient care
Number of subjects: 44
Study 15651051 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (1000 mg)
Number of subjects: 33
Study 15651051 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (900 mg)
Number of subjects: 33
Study 15651051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 12003257 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol-enriched spread (8.3% sterol content, 25 g/day)
Number of subjects: 42
Study 12003257 — intervention group
Group type: COMPARATOR
Intervention: Control spread (35% fat, similar fat composition)
Number of subjects: 42
Study 10411835 — intervention group
Group type: EXPERIMENTAL
Intervention: Marshall‐Marchetti‐Krantz urethropexy
Number of subjects: 30
Study 10411835 — intervention group
Group type: COMPARATOR
Intervention: Burch colposuspension
Number of subjects: 30
Study 7486351 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual world training
Number of subjects: 0
Study 7486351 — intervention group
Group type: COMPARATOR
Intervention: Real world training
Number of subjects: 0
Study 2181689 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam
Number of subjects: 68
Study 2181689 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin
Number of subjects: 68
Study 381873 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg twice daily)
Number of subjects: 51
Study 381873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 31433396 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrophosphate-based mouth rinse (B)
Number of subjects: 40
Study 31433396 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinse (A)
Number of subjects: 40
Study 30139208 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated within the previous 10 years
Number of subjects: 200
Study 30139208 — intervention group
Group type: COMPARATOR
Intervention: Graduated between 10 and 20 years
Number of subjects: 200
Study 30139208 — intervention group
Group type: COMPARATOR
Intervention: Graduated more than 20 years ago
Number of subjects: 200
Study 30139208 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall knowledge score
Number of subjects: 200
Study 25888662 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor strengthening exercises with electrotherapy
Number of subjects: 24
Study 25888662 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor strengthening exercises without electrotherapy (control group)
Number of subjects: 24
Study 25154778 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified rice (cold and hot extruded)
Number of subjects: 2011
Study 25154778 — intervention group
Group type: COMPARATOR
Intervention: Conventional rice
Number of subjects: 2011
Study 22799613 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination treatment (OM 40 mg/AML 10 mg/HCTZ 25 mg)
Number of subjects: 2492
Study 22799613 — intervention group
Group type: COMPARATOR
Intervention: Dual-combination treatments (OM 40 mg/AML 10 mg, OM 40 mg/HCTZ 25 mg, or AML 10 mg/HCTZ 25 mg)
Number of subjects: 2492
Study 20173299 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 17278987 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (perindopril-based therapy, with possible addition of indapamide)
Number of subjects: 357
Study 17278987 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 357
Study 15644658 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation algorithm (algorithm group)
Number of subjects: 102
Study 15644658 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 102
Study 12681371 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.23 mg/kg ketamine hydrochloride followed by 0.5 mg/kg ketamine over 45 min
Number of subjects: 20
Study 12681371 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study 10964037 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength measurement instrument using a strain gauge force transducer, bridge amplifier, and mechanical structure; assessed for reproducibility in ALS patients and normal subjects.
Number of subjects: 41
Study 10964037 — intervention group
Group type: COMPARATOR
Intervention: Interexaminer reproducibility assessed in ALS patients and normal subjects.
Number of subjects: 41
Study 9006256 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft bedding (very soft mattress)
Number of subjects: 0
Study 9006256 — intervention group
Group type: COMPARATOR
Intervention: Hard mattress
Number of subjects: 0
Study 1320287 — intervention group
Group type: EXPERIMENTAL
Intervention: nedocromil sodium (4 mg q.i.d.)
Number of subjects: 165
Study 1320287 — intervention group
Group type: EXPERIMENTAL
Intervention: sodium cromoglycate (10 micrograms q.i.d.)
Number of subjects: 165
Study 1320287 — intervention group
Group type: EXPERIMENTAL
Intervention: beclomethasone dipropionate (500 micrograms t.i.d.)
Number of subjects: 165
Study 6095322 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg ACTH 4‐9 analog, ORG 2766
Number of subjects: 10
Study 6095322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31533783 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity problem-solving intervention delivered over 3 weeks by lay counsellors
Number of subjects: 240
Study 31533783 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care comprised of problem-solving booklets
Number of subjects: 240
Study 31533783 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity problem-solving intervention
Number of subjects: 240
Study 31533783 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 240
Study 31533783 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom-based sensitization intervention
Number of subjects: 240
Study 31533783 — intervention group
Group type: COMPARATOR
Intervention: School-level sensitization activities
Number of subjects: 240
Study 29172596 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPS intervention
Number of subjects: 280
Study 29172596 — intervention group
Group type: EXPERIMENTAL
Intervention: CHIEF intervention
Number of subjects: 280
Study 26053189 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic interval training (3‐min intervals at 40% and 80% VO2peak for 30 mins/day, 3 days/wk for 12 wks)
Number of subjects: 120
Study 24299513 — intervention group
Group type: EXPERIMENTAL
Intervention: Larval therapy dressing (BioFOAM)
Number of subjects: 88
Study 24299513 — intervention group
Group type: COMPARATOR
Intervention: Hydrogel (Purilon gel)
Number of subjects: 88
Study 22540269 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiopaque ENG implant
Number of subjects: 52
Study 22540269 — intervention group
Group type: COMPARATOR
Intervention: Non-radiopaque ENG implant
Number of subjects: 52
Study 20189173 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventrogluteal site
Number of subjects: 580
Study 20189173 — intervention group
Group type: COMPARATOR
Intervention: Anterolateral thigh site
Number of subjects: 580
Study 17510461 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition from household ambulation to limited community ambulation (68% of 19 household ambulators)
Number of subjects: 64
Study 17510461 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition from limited community ambulation to full community ambulation (38% of 45 limited community ambulators)
Number of subjects: 64
Study 16170947 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented force-feedback fields with gradual start and abrupt ending
Number of subjects: 0
Study 16170947 — intervention group
Group type: COMPARATOR
Intervention: Electromechanical force-feedback trackball (control device)
Number of subjects: 0
Study 16170947 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender effect observed
Number of subjects: 0
Study 12066212 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral doxifluridine (5'‐DFUR)
Number of subjects: 482
Study 12066212 — intervention group
Group type: COMPARATOR
Intervention: Oral 5‐fluorouracil (5‐FU)
Number of subjects: 482
Study 9891531 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐FU plus HCFU (group A)
Number of subjects: 251
Study 9891531 — intervention group
Group type: COMPARATOR
Intervention: 5‐FU injections only (group B)
Number of subjects: 251
Study 8069985 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipecuronium 100 micrograms.kg‐1
Number of subjects: 30
Study 8069985 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium 150 micrograms.kg‐1
Number of subjects: 30
Study 8069985 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipecuronium
Number of subjects: 30
Study 2962837 — intervention group
Group type: EXPERIMENTAL
Intervention: Procaterol 0.1 mg
Number of subjects: 10
Study 2962837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30840085 — intervention group
Group type: EXPERIMENTAL
Intervention: iPACT‐E‐Trauma (self‐management intervention)
Number of subjects: 56
Study 30840085 — intervention group
Group type: COMPARATOR
Intervention: Educational pamphlet (control)
Number of subjects: 56
Study 30409195 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 10
Study 30409195 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 10
Study 30409195 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based health coaching
Number of subjects: 10
Study 30409195 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (real and sham) with lifestyle interventions
Number of subjects: 10
Study 26597414 — intervention group
Group type: EXPERIMENTAL
Intervention: Walk On! physical activity coaching intervention
Number of subjects: 1650
Study 26597414 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1650
Study 25129551 — intervention group
Group type: EXPERIMENTAL
Intervention: RCHT + EPO
Number of subjects: 385
Study 25129551 — intervention group
Group type: COMPARATOR
Intervention: RCHT
Number of subjects: 385
Study 22711428 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) 24 IU
Number of subjects: 45
Study 22711428 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (LZP) 2 mg
Number of subjects: 45
Study 22711428 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 45
Study 20562609 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat Back (RB) method added to iMedConsent
Number of subjects: 575
Study 20562609 — intervention group
Group type: COMPARATOR
Intervention: Standard iMedConsent (no RB)
Number of subjects: 575
Study 20562609 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat Back (RB) method for carotid endarterectomy patients
Number of subjects: 575
Study 20562609 — intervention group
Group type: COMPARATOR
Intervention: Standard iMedConsent (no RB) for carotid endarterectomy patients
Number of subjects: 575
Study 20562609 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat Back (RB) method
Number of subjects: 575
Study 17605816 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert panel assessment of paired images (better/worse decision)
Number of subjects: 64
Study 17605816 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent readers scoring using the van der Heijde-modified Sharp method
Number of subjects: 64
Study 17605816 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of repair features by expert panel
Number of subjects: 64
Study 17605816 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in size of erosion
Number of subjects: 64
Study 16129086 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate/high-protein diet
Number of subjects: 28
Study 16129086 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate/low-fat diet
Number of subjects: 28
Study 12092746 — intervention group
Group type: EXPERIMENTAL
Intervention: Encapsulated enteric-coated beads (400 mg)
Number of subjects: 76
Study 12092746 — intervention group
Group type: COMPARATOR
Intervention: Buffered tablet (400 mg)
Number of subjects: 76
Study 10345908 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite Intervention
Number of subjects: 1359
Study 10345908 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite Plus Family Intervention
Number of subjects: 1359
Study 10345908 — intervention group
Group type: COMPARATOR
Intervention: Minimal Intervention
Number of subjects: 1359
Study 8697497 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-laser treatment
Number of subjects: 0
Study 8697497 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcurrent electrical stimulation (MENS)
Number of subjects: 0
Study 8697497 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 2530020 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial ANF concentrations
Number of subjects: 10
Study 2530020 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous ANF concentrations
Number of subjects: 10
Study 2530020 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraction ratios for ANF
Number of subjects: 10
Study 2530020 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma ANF concentration in a peripheral arm vein
Number of subjects: 10
Study 130574 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lidocaine
Number of subjects: 100
Study 130574 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 100
Study 7010982 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose
Number of subjects: 20
Study 7010982 — intervention group
Group type: EXPERIMENTAL
Intervention: Potato
Number of subjects: 20
Study 7010982 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice
Number of subjects: 20
Study 7010982 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn
Number of subjects: 20
Study 7010982 — intervention group
Group type: EXPERIMENTAL
Intervention: Bread
Number of subjects: 20
Study 31963598 — intervention group
Group type: EXPERIMENTAL
Intervention: Aislados intervention program (video game)
Number of subjects: 187
Study 31963598 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 187
Study 31432220 — intervention group
Group type: EXPERIMENTAL
Intervention: FREEWAY™ drug‐eluting balloon
Number of subjects: 204
Study 31432220 — intervention group
Group type: COMPARATOR
Intervention: Standard PTA balloon angioplasty
Number of subjects: 204
Study 27344103 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive restructuring and imagery modification (CRIM-PTSD)
Number of subjects: 10
Study 26038960 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid (INH) 300 mg formulation
Number of subjects: 28
Study 26038960 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid (INH) 100 mg formulation (reference product)
Number of subjects: 28
Study 24588117 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic HAE patients
Number of subjects: 68
Study 24588117 — intervention group
Group type: EXPERIMENTAL
Intervention: During clinical attack
Number of subjects: 68
Study 24588117 — intervention group
Group type: EXPERIMENTAL
Intervention: During next 24 hours of abdominal attack
Number of subjects: 68
Study 24588117 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-attack levels in abdominal attack patients
Number of subjects: 68
Study 22622364 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) using the Moja-De protocol
Number of subjects: 24
Study 22622364 — intervention group
Group type: COMPARATOR
Intervention: TRP-balanced amino acid load (BAL)
Number of subjects: 24
Study 19404717 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised New Forest Parenting Programme (NFPP)
Number of subjects: 41
Study 19404717 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 41
Study 17523968 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes service model intervention in community pharmacies over 6 months
Number of subjects: 289
Study 17523968 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes service model intervention in community pharmacies
Number of subjects: 289
Study 17523968 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 289
Study 15090169 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised protocol stating confidentiality would be broken if a youth reported suicidal ideation
Number of subjects: 0
Study 11279594 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory assessment after 1 week for 6-month-olds
Number of subjects: 2
Study 11279594 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory assessment after 1 week for 3-month-olds
Number of subjects: 2
Study 11279594 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing complexity of learned information
Number of subjects: 2
Study 9730427 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 73
Study 9730427 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 73
Study 9730427 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Tacrolimus
Number of subjects: 73
Study 9730427 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Tacrolimus
Number of subjects: 73
Study 7995668 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication processes related to alcohol
Number of subjects: 0
Study 7995668 — intervention group
Group type: EXPERIMENTAL
Intervention: Social, situational, and individual factors related to alcohol
Number of subjects: 0
Study 3292249 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine citrate (loading dose 20 mg/kg, maintenance dose 10 mg/kg per day)
Number of subjects: 50
Study 3292249 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 50
Study 3292249 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine citrate
Number of subjects: 50
Study 3292249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 29718460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarettes with 2.4-0.4 mg/g nicotine
Number of subjects: 0
Study 29718460 — intervention group
Group type: COMPARATOR
Intervention: Cigarettes with usual-brand nicotine content
Number of subjects: 0
Study 28538644 — intervention group
Group type: EXPERIMENTAL
Intervention: CD28 immunomodulator (AB103) at 0.5 mg/kg, n = 15
Number of subjects: 198
Study 28538644 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n = 10
Number of subjects: 198
Study 28538644 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospective data set (all patients)
Number of subjects: 198
Study 28538644 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospective data set (high disease severity, mSOFA > 3)
Number of subjects: 198
Study 28538644 — intervention group
Group type: EXPERIMENTAL
Intervention: NICCE success
Number of subjects: 198
Study 25415414 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-second roller massager application
Number of subjects: 10
Study 25415414 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-second roller massager application
Number of subjects: 10
Study 25415414 — intervention group
Group type: COMPARATOR
Intervention: Control condition (participants sat quietly)
Number of subjects: 10
Study 25415414 — intervention group
Group type: EXPERIMENTAL
Intervention: Roller massage (both conditions)
Number of subjects: 10
Study 23438677 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal plus isoflurane anesthesia
Number of subjects: 106
Study 23438677 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal plus desflurane anesthesia
Number of subjects: 106
Study 23438677 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia
Number of subjects: 106
Study 23438677 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal plus isoflurane anesthesia and spinal plus desflurane anesthesia
Number of subjects: 106
Study 21809698 — intervention group
Group type: EXPERIMENTAL
Intervention: anvifen (aminophenylbutyric acid)
Number of subjects: 18
Study 21809698 — intervention group
Group type: COMPARATOR
Intervention: phenibut tablets
Number of subjects: 18
Study 19380382 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (6 mg)
Number of subjects: 21
Study 16409440 — intervention group
Group type: EXPERIMENTAL
Intervention: Darifenacin 15 mg once daily (qd)
Number of subjects: 445
Study 16409440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 445
Study 15700749 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroalcoholic extract of C. curvisepala Lind. (3 times daily for more than 4 months)
Number of subjects: 92
Study 15700749 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 times daily for more than 4 months)
Number of subjects: 92
Study 10589324 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent educational intervention
Number of subjects: 280
Study 10589324 — intervention group
Group type: COMPARATOR
Intervention: Routine medical care (Control)
Number of subjects: 280
Study 8914345 — intervention group
Group type: EXPERIMENTAL
Intervention: I.D. microtyping system (Diamed)
Number of subjects: 1000
Study 8914345 — intervention group
Group type: COMPARATOR
Intervention: Biovue system (Ortho Diagnostics)
Number of subjects: 1000
Study 1649718 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin treatment (36 units/kg intravenously three times a week for 6 months, then 18 units/kg three times a week for 6 months)
Number of subjects: 21
Study 1649718 — intervention group
Group type: EXPERIMENTAL
Intervention: Desferrioxamine chelation therapy (30 mg/kg intravenously three times a week for 6 months)
Number of subjects: 21
Study 1649718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 6404174 — intervention group
Group type: EXPERIMENTAL
Intervention: Adriamycin plus cisplatin
Number of subjects: 273
Study 6404174 — intervention group
Group type: COMPARATOR
Intervention: cisplatin alone
Number of subjects: 273